CytoView MEA plate, the premium Maestro multiwell microelectrode array (MEA) plate, combines unparalleled access to cellular electrical network information with a thin, transparent well bottom for culture visualization and assay multiplexing.
Available in 6-, 24-, 48-, and 96-well formats (see table below), CytoView MEA plates contain the industry-leading electrode count per well (up to 64 electrodes per well), deliver low-noise signals, and can be read over days, weeks, or months.
Get more from every assay.
Record high quality data - Industry-leading electrode count for detailed information from your cardiac and neural assays. PEDOT electrode technology ensures collection of the highest quality signals.
See your cells with transparent plates - Compatible with light microscopy for daily culture monitoring.
Assay multiplexing enriches MEA data - Multiplex your assay with top- or bottom-read fluorescent and luminescent plate readers. Choose between black or white walls for optimal application flexibility.
*Schematic of well illustrating recording electrodes (blue), grounds (orange), and where present, a large dedicated stimulation (blue).
Cell visualization and assay multiplexing
The innovative, transparent plate bottom offers additional assay flexibility including cell visualization and assay multiplexing. Bright field imaging enables confirmation of cell spotting accuracy and correlation of cell culture health and connectivity with MEA results. Multiplex fluorescence- or luminescence-based assays with your MEA study to probe complementary end points.
High quality MEA data
Both cardiomyocytes and neurons perform well on the CytoView MEA plates, showing excellent coverage across all wells and the high signal-to-noise ratio Axion customers expect.
Assay multiplexing enriches MEA data
With the transparent CytoView MEA plates, reporter-based (ex. fluorescent or luminescent) assays can be used to complement MEA data generated from the same well. The combination of electrophysiological data with reporter-based assays can provide supplementary information regarding compound mechanism of action.
In this neurotoxicity assay, compound were assessed using MEA electrophysiology data from Axion’s Maestro MEA system multiplexed with a fluorescence lactate dehydrogenase (LDH) cell viability assay. Multiplexing enabled greater specificity for compound classification compared to MEA data alone. (A) Both deltamethrin and tributyltin reduced mean firing rate, but (B) only tributyltin reduced cell viability. (Data provided by external customer)